nothing unusual with medicine approval process with FDA. sentiment changes but fundamentally speaking , it is all about right track.
- Forums
- ASX - By Stock
- Ann: Neuren approaching key milestones in Q4 2019
nothing unusual with medicine approval process with FDA....
-
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.71 |
Change
-0.560(2.63%) |
Mkt cap ! $2.657B |
Open | High | Low | Value | Volume |
$20.98 | $21.06 | $20.40 | $1.674M | 80.70K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34 | $20.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.72 | 40 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 43 | 20.660 |
4 | 176 | 20.650 |
5 | 387 | 20.640 |
5 | 354 | 20.630 |
5 | 685 | 20.620 |
Price($) | Vol. | No. |
---|---|---|
20.690 | 20 | 1 |
20.700 | 131 | 4 |
20.710 | 148 | 2 |
20.720 | 192 | 4 |
20.730 | 316 | 3 |
Last trade - 11.54am 01/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
Previous Video
Next Video
SPONSORED BY The Market Online